ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628561; 2) Community: the network communities that were significantly associated with the response to NSC 628561; 3) Molecule: the relationships between components within communities and NSC 628561; 4) MDR: the compounds that were significantly associated with the NSC 628561.

NSC Compound Enrichment Correlation
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0114553853234976 -0.071346239
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0114553853234977 0.2736191
NSC 135880 Null 0.0114553853234977 0.25618302
NSC 335995 Null 0.0114553853234977 0.29158465
NSC 339137 PHYSALOLACTONE 0.0114553853234977 0.39280964
NSC 42972 Null 0.0114553853234977 0.34592774
NSC 624657 ANTINEOPLASTIC-624657 0.0114553853234977 0.41290101
NSC 625985 Null 0.0119653763676521 0.3322114
NSC 632877 Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) 0.0119653763676522 0.52110057
NSC 666667 Null 0.0119653763676522 0.56444747
Total:91  Current:29    [First] [Prev] [Next] [Last]